FDA Approves Apalutamide (Erleada); the first treatment for non-metastatic castration-resistant prostate cancer (READ MORE HERE).
Noninvasive Radiofrequency Field for the Targeted Destruction..
The William Bikoff Creativity Award
The University of Texas MD Anderson Cancer Center
Metastatic prostate cancer is essentially incurable and..
Kathryn Wilson, ScD:
Harvard School of Public Health
Lorelei Mucci, ScD, Matthew Smith, MD, PhD
Bone Metabolism and Bone Metastases in Prostate Cancer
Castrate-resistant prostate cancer (CRPC) is an aggressive,..
Yu Wang, MD, PhD:
New York University Lagone Medical Center
Susan Logan, PhD, Michael Garabedian, PhD
Multivalent Peptidomimetic Conjugates in CRPC Treatment
The identification of biomarkers to stratify risk..
Li Wang, PhD:
Icahn School of Medicine at Mount Sinai
William Oh, MD and Eric Schadt, PhD
Integrative Genomics Study of Immune Signatures in Blood and Tumor Tissue for Prostate Cancer
Exploration of the Relationship between In Vivo..
Peter MacCallum Cancer Centre, Australia
Target identification Combining In Vivo Tissue Transformation..
Distinguished Professor of Microbiology, Immunology, and Molecular Genetics
President's Chair in Developmental Immunology
David Geffen School of Medicine
University of California, Los Angeles
Identification of biomarkers to stratify risk for..
Integrative genomics study of immune signatures in blood and tumor tissue for prostate cancer
Dr. Hong Wu is dedicated to discovering..
When his father was first diagnosed with..
Janet Farrar Worthington is an award-winning science..